ILMN:NASDAQ
Illumina Inc
$211.06
arrow_downward
-3.28%(-7.16) 1D
$212.00
arrow_upward
+0.45% (+0.94)bedtimeAfter hours
Closed: Sep 8, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ILMN...
Open
$218.65
High
$219.45
Low
$210.15
Mkt. cap
31.87B
Avg. vol.
2.01M
Volume
1.82M
P/E ratio
39.23
52-wk high
$231.81
52-wk low
$88.00
EPS
$5.38
Beta
1.46
Shares outstanding
151.00M
No. of employees
9K
Open
$218.65
High
$219.45
Low
$210.15
Mkt. cap
31.87B
Avg. vol.
2.01M
Volume
1.82M
P/E ratio
39.23
52-wk high
$231.81
52-wk low
$88.00
EPS
$5.38
Beta
1.46
Shares outstanding
151.00M
No. of employees
9K
News stories
From web sources and news partners
Zacks
·
2 hours ago
3 Stocks Soon Joining the S&P 500
GuruFocus
·
4 hours ago
A Look at Illumina Inc (ILMN) After 3.3% Decline -- GF Value $132.76 vs Price $211.06
Stock Traders Daily
·
7 hours ago
Responsive Playbooks and the ILMN Inflection
Trefis
·
7 hours ago
ILMN Stock Keeps Climbing. Should You Climb On?
Profile
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.
Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies. Wikipedia
About Illumina Inc
CEOJacob Thaysen
Employees8.62K
Founded1998
HeadquartersSan Diego, California, United States
SectorHealth care
Websiteillumina.com